Add office photos
Employer?
Claim Account for FREE
Piramal Pharma
4.0
based on 919 Reviews
Company Overview
Company Locations
Working at Piramal Pharma
Company Summary
Piramal Pharma Solutions strives to enhance value for the patients by reducing the burden of disease through early-stage drug discovery and clinical development services.
Overall Rating
4.0/5
based on 919 reviews
3% above
industry average
Highly rated for
Job Security, Company Culture, Skill Development
Critically rated for
Promotions/Appraisal
Work Policy
Work from office
71% employees reported
Monday to Saturday
44% employees reported
Flexible timing
53% employees reported
No travel
53% employees reported
View detailed work policy
Top Employees Benefits
Health insurance
74 employees reported
Office cab/shuttle
61 employees reported
Job/Soft skill training
61 employees reported
Free meal
51 employees reported
View all benefits
About Piramal Pharma
Founded in2020 (5 yrs old)
India Employee Count1k-5k
Global Employee Count1k-5k
HeadquartersMumbai, Maharashtra, India
Office Locations
Websitepiramalpharma.com
Primary Industry
Other Industries
Are you managing Piramal Pharma's employer brand? To edit company information,
claim this page for free
Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter consumer and wellness products.
*Includes one facility through minority investment in Yapan Bio
Managing your company's employer brand?
Claim this Company Page for FREE
Report error
Piramal Pharma Ratings
based on 919 reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
422
4
269
3
109
2
46
1
73
Category Ratings
3.8
Job Security
3.8
Company Culture
3.8
Skill Development
3.8
Salary & Benefits
3.8
Work-Life Balance
3.6
Work Satisfaction
3.3
Promotions/Appraisal
Piramal Pharma is rated 4.0 out of 5 stars on AmbitionBox, based on 919 company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Piramal Pharma
based on 888 reviews
3.9
Rated by 89 Women
Rated 3.8 for Job Security and 3.7 for Work-Life Balance
4.0
Rated by 799 Men
Rated 3.8 for Company Culture and 3.8 for Job Security
Work Policy at Piramal Pharma
based on 161 reviews in last 6 months
Work from office
71%
Hybrid
27%
Permanent work from home
2%
Piramal Pharma Reviews
Top mentions in Piramal Pharma Reviews
+ 5 more
Compare Piramal Pharma with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 919 reviews | 3.9/5 based on 139 reviews | 3.8/5 based on 1.3k reviews | 4.0/5 based on 868 reviews |
Highly Rated for | Job Security Company culture Skill development | Skill development Promotion/Appraisals Job Security | Job Security | Skill development |
Critically Rated for | Promotion/Appraisals | No critically rated category | Work Satisfaction Company culture Promotion/Appraisals | Job Security Promotion/Appraisals |
Primary Work Policy | Work from office 71% employees reported | Work from office 87% employees reported | Work from office 91% employees reported | Work from office 91% employees reported |
Rating by Women Employees | 3.9 Good rated by 89 women | 3.8 Good rated by 17 women | 4.0 Good rated by 146 women | 4.0 Good rated by 127 women |
Rating by Men Employees | 4.0 Good rated by 799 men | 3.9 Good rated by 114 men | 3.8 Good rated by 1.1k men | 4.0 Good rated by 713 men |
Job Security | 3.8 Good | 3.8 Good | 4.0 Good | 3.2 Average |
View more
Piramal Pharma Salaries
3.8
rated by 919 employees for salariesSenior Research Associate
(411 salaries)
Unlock
₹2.3 L/yr - ₹9.6 L/yr
Team Member
(189 salaries)
Unlock
₹2.3 L/yr - ₹6 L/yr
Chemist
(165 salaries)
Unlock
₹1.5 L/yr - ₹4.2 L/yr
Research Scientist
(132 salaries)
Unlock
₹4.3 L/yr - ₹13 L/yr
Production Chemist
(115 salaries)
Unlock
₹1.4 L/yr - ₹4.5 L/yr
Executive Production
(91 salaries)
Unlock
₹1.9 L/yr - ₹6.6 L/yr
Deputy Manager
(77 salaries)
Unlock
₹6 L/yr - ₹13.2 L/yr
Research Associate
(73 salaries)
Unlock
₹2 L/yr - ₹6.5 L/yr
Sales Officer
(66 salaries)
Unlock
₹3.4 L/yr - ₹6.5 L/yr
QA Executive
(46 salaries)
Unlock
₹2 L/yr - ₹9.5 L/yr
Piramal Pharma Interview Questions
Interview questions by designation
Top Piramal Pharma interview questions and answers
Get interview-ready with top interview questions
Interview Process at Piramal Pharma
based on 26 interviews in last 1 year
Interview Experience
3.9
Good
Difficulty level
Easy
11%
Moderate
78%
Hard
11%
People are getting interviews through
based on 62 Piramal Pharma interviews
Job Portal
29%
Referral
16%
Walkin
16%
Company Website
13%
*26% candidates got the interview through other sources
High confidence
Piramal Pharma Jobs
Piramal Pharma News
View all
Piramal Pharma Is Jefferies' Top Pick Among Contract Manufacturers With Sector Outlook Positive
- Jefferies sees 2025 as a year of reckoning for Contract Development and Manufacturing Organization (CDMO) stocks.
- Piramal Pharma Ltd. is Jefferies' top pick among contract manufacturers with expectations of margin expansion due to operating leverage.
- CDMO stocks delivered strong returns in 2024, outperforming Nifty and Nifty Pharma, despite mixed earnings.
- Investor confidence in the long-term story of CDMOs has grown, driven by increased optimism and positive management commentary.
Bloomberg Quint | 10 Jan, 2025
Piramal Pharma To M&M: ICICI Securities Shares Top Stock Picks For 2025
- Piramal Pharma Ltd., Mahindra and Mahindra Ltd., KNR Construction Ltd. and Narayana Hrudalaya Ltd. are among ICICI Securities' top stock picks for 2025.
- ICICI Securities expects Nifty 50 to reach the 28,300-mark in 2025, while the target for BSE Sensex is 94,300.
- ICICI Securities predicts a healthy double-digit upside in broader markets in CY25 and projects Nifty earnings to grow at a CAGR of 15% over fiscal 2025-27.
- Investors are advised to focus on companies with growth longevity, healthy balance sheets, and capital-efficient business models, according to ICICI Securities.
Bloomberg Quint | 30 Dec, 2024
Trading Ideas: Sell Axita Cotton, Hold Piramal Pharma, Siemens, Skipper, Experts Say
- Market experts suggest selling Axita Cotton Ltd.
- Hold recommendations for Piramal Pharma Ltd., Siemens Ltd., and Skipper Ltd.
- Kush Bohra advises selling Axita Cotton Ltd. as he sees no upside potential.
- Shahina Mukadam suggests a switch to larger banks for short-term holding period and recommends holding Piramal Pharma, Siemens, and Skipper.
Bloomberg Quint | 19 Dec, 2024
Piramal Pharma Share Price Jumps After JM Financial Initiates 'Buy'
- Piramal Pharma Ltd.'s share price rose nearly 5% after JM Financial initiated coverage on the stock with a 'buy' rating.
- Piramal's consumer healthcare segment is on the verge of scaling up with additional capacity and a pipeline of 24 injectable products.
- The hospital generics business of Piramal Pharma specializes in complex inhalation and injectable products with high entry barriers.
- The stock has risen 110.27% in the last 12 months and 92.19% year-to-date, with all 10 analysts tracking the pharma having a 'buy' rating.
Bloomberg Quint | 17 Dec, 2024
JM Financial Initiates 'Buy' On Piramal Pharma Citing Robust Pipeline, Global Manufacturing Presence
- JM Financial Institutional Securities Ltd. has initiated coverage on Piramal Pharma Ltd. with a 'buy' rating.
- Piramal Pharma's Contract Development and Manufacturing Organisation segment, which contributes 58% to its revenue, is the company's growth engine.
- The segment is expected to achieve a 17% compound annual growth rate over the next three years, supported by newly commercialised molecules and a rebound in the US biotech sector.
- JM Financial projects a 13% CAGR for Piramal Pharma's consumer healthcare segment over the next three years, while the hospital generics business is expected to grow at 11% CAGR.
Bloomberg Quint | 17 Dec, 2024
Buy, Sell Or Hold: LIC, Piramal Pharma, Mamaearth, Tata Power, Titagarh Rail Systems — Ask Profit
- Market analysts share insights for short-term and long-term investors on whether to buy, sell or hold shares of LIC, Tata Power, Hyundai Motors, Mamaearth, and Piramal Pharma, among others.
- Tata Power: Analyst suggests to hold with a target of Rs 500 level.
- LIC: Analyst suggests to hold with a target of Rs 1,150-1,200 level.
- Piramal Pharma: Analyst suggests to hold with a target of Rs 325-350 (9-12 month horizon) or Rs 400-plus (more than two years) level.
- Titagarh Rail Systems: Analyst suggests to buy with a target of Rs 1,450 to Rs 1,500 plus level.
Bloomberg Quint | 12 Dec, 2024
Share Market Highlights: Sensex, Nifty dip; RBI’s CRR cut eases liquidity worries
- The GDP growth projection for FY25 has been slashed to 6.6% from the earlier 7.2% indicating the effects of high food inflation.
- The RBI has continued to maintain a neutral stance to support growth and indicate a low-rate regime in sight.
- Tata Motors and Bajaj Auto were among the top gainers while Cipla and Adani Ports were among the top losers.
- UltraTech Cement slipped 0.73% on the NSE, while Piramal Pharma’s stock fell 2.55% on the NSE.
- Nifty index remains in buy on dips mode as it traded higher for the past 5 trading sessions.
- According to Jefferies, the current price action suggests that the index may move further upwards.
- Mishtann Foods' stock plummeted 19.97% on the BSE after SEBI ordered the company to recover nearly Rs. 100 crore.
- RBI’s Monetary Policy meeting was held today.
- As per the report, liquidity management crucial, CRR cut a possibility.
- Indian IPO market soars to $17.3 bn so far in 2024 and is nearing record highs.
HinduBusinessLine | 6 Dec, 2024
Powered by
Compare Piramal Pharma with
Biocon Limited
3.9
DRJ & CO
5.0
Sun Pharmaceutical Industries
4.0
Cipla
4.1
Glenmark Pharmaceuticals
3.9
Lupin
4.2
Aurobindo Pharma
4.0
Micro Labs
3.7
GlaxoSmithKline Pharmaceuticals
4.1
Novartis
4.1
Biological E
4.2
Granules India
3.9
Gland Pharma
3.8
Sanofi
4.3
Unichem Laboratories
3.9
Fresenius Kabi
4.2
ACG Worldwide
4.0
Novo Nordisk
4.1
Jubilant Pharmova
3.9
Hikal
3.9
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Piramal Pharma
DIVI'S Laboratories
Pharma
3.8
• 1.3k reviews
Suven Life Sciences
Clinical Research, Pharma
3.9
• 139 reviews
Strides Pharma
Pharma
4.0
• 868 reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.8k reviews
DRJ & CO
Architecture & Interior Design
5.0
• 1 reviews
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.6k reviews
Cipla
Manufacturing, Pharma
4.1
• 6.6k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.7k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 5.8k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.6k reviews
Micro Labs
Clinical Research, Pharma
3.7
• 2.1k reviews
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 1.8k reviews
Piramal Pharma FAQs
When was Piramal Pharma founded?
Piramal Pharma was founded in 2020. The company has been operating for 5 years primarily in the Pharma sector.
Where is the Piramal Pharma headquarters located?
Piramal Pharma is headquartered in Mumbai, Maharashtra and has an office in Mumbai
How many employees does Piramal Pharma have in India?
Piramal Pharma currently has more than 4,600+ employees in India. Research & Development department appears to have the highest employee count in Piramal Pharma based on the number of reviews submitted on AmbitionBox.
Does Piramal Pharma have good work-life balance?
Piramal Pharma has a Work-Life Balance Rating of 3.8 out of 5 based on 900+ employee reviews on AmbitionBox. 75% employees rated Piramal Pharma 4 or above, while 25% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Piramal Pharma work-life balance reviews for more details
Is Piramal Pharma good for career growth?
Career growth at Piramal Pharma is rated as moderate, with a promotions and appraisal rating of 3.3. 25% employees rated Piramal Pharma 3 or below, while 75% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Piramal Pharma promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Piramal Pharma?
Working at Piramal Pharma comes with several advantages and disadvantages. It is highly rated for job security, company culture and skill development. However, it is poorly rated for promotions / appraisal, based on 900+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
